A common blood test for ovarian cancer is more likely to fall short for Black and Native American women
A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
The Healthy @Reader's Digest4d
“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily Exercise
A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...
HealthDay on MSN7d
CA-125 Levels Vary by Patient Race at Ovarian Cancer Diagnosis
Black and American Indian patients are less likely to have elevated cancer antigen (CA)-125 levels at ovarian cancer ...
Blood test for ovarian cancer misses some Black and Native American patients, study finds
A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...
Health and Me on MSN3d
Ovarian Cancer Test May Be Less Effective For Black And Native American Patients
Ovarian cancer is the fifth leading cause of cancer-related deaths among women in the U.S. However, the racial bias makes it ...
Medscape10d
CA-125 Shows Less Accuracy in Black and American Indian Patients with Ovarian Cancer
Researchers examined CA-125 levels at diagnosis, defining them as elevated/borderline or negative/normal in 250,749 patients ...
PipelineReview.com6h
Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
REDWOOD CITY, CA, USA I March 31, 2025 I Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development ...
'I had signs of ovarian cancer and want others to know them'
There is no national ovarian cancer screening programme as, according to the NHS, there is not a test that can reliably pick ...
Mural Oncology to Discontinue Ovarian Cancer Drug Candidate as Trial Misses Targets
Mural Oncology said that it won't continue developing its ovarian cancer drug candidate Nemvaleukin to be used in conjunction with Merck's Keytruda after results showed no statistical improvement in ...
The Associated Press on MSN11d
Blood test for ovarian cancer misses some Black, Native American patients: Study
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...
clinicaladvisor.com6d
CA-125 Levels Vary by Patient Race at Ovarian Cancer Diagnosis
The likelihood of having an elevated CA-125 level at ovarian cancer diagnosis was lower for American Indian, Asian, or Black patients versus White patients. HealthDay News — Black and American ...
STAT11d
Blood test for ovarian cancer misses some Black and Native American patients, study finds
The researchers analyzed data from more than 200,000 women with ovarian cancer from 2004 through 2020 who’d had a CA-125 blood test. Black and Native American patients were 23% less likely to ...